Durenard Eugene

Track

Insider profile

Performance

Overall performance
3.3
Performance over holding periods
3.3
30 days 90 days 120 days
Average return -4% 8.2% 15.1%
Success rate 82% 68% 82%
Transactions
4 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Durenard Eugene's trades of Co-Diagnostics Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Sale
Price
160.14
Quantity 74,508 +32.3%
Value US$4,778,130
Transaction date
Sale
Price
34.58
Quantity 66,918 +1.5%
Value US$4,143,223
Transaction date
Sale
Price
479.59
Quantity 70,219 +30.5%
Value US$2,990,938
Transaction date
Sale
Price
18.40
Quantity 25,000 -100.0%
Value US$460,000
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2021-01-15 2021-01-13
S Sale
74,508 +32.3%
160.14
US$4,778,130 		74,508 +32.3% 160.14 US$4,778,130
2020-12-14 2020-12-10
S Sale
66,918 +1.5%
34.58
US$4,143,223 		66,918 +1.5% 34.58 US$4,143,223
2020-06-05 2020-05-26
S Sale
70,219 +30.5%
479.59
US$2,990,938 		70,219 +30.5% 479.59 US$2,990,938
2020-06-05 2020-05-20
S Sale
25,000 -100.0%
18.40
US$460,000 		25,000 -100.0% 18.40 US$460,000